BioSpace News Archive

Tricida, Inc. announced that, due to public health concerns relating to the coronavirus pandemic and to protect the health of its employees, directors and stockholders, its 2020 annual meeting of stockholders will be held in a virtual-only format.

Transplant Genomics, Inc. and Viracor Eurofins, announce the formation of the Eurofins Transplant Medical and Scientific Advisory Board, employing diverse expertise and experience in transplantation technology development and clinical studies to enhance the clinical value of diagnostics throughout the transplant community.

Fractyl Laboratories Inc. ( Fractyl ) today announced that the company has received approval from the U.S. Food and Drug Administration (FDA) of an Investigational Device Exemption (IDE) to begin a pi

Artelo Biosciences, Inc. (NASDAQ: ARTL) , a clinical stage biopharmaceutical company developing therapeutics that modulate the endocannabinoid system and related pathways, announced today that it will be participating in two upcoming virtual conferences. Gregory D. Gorgas, President and Chief Executive Officer of Artelo Biosciences, will be speaking on a panel entitled, “Disruptive Thinking: What’s Next for Pain,” at BIO Digital being

Cytovia Therapeutics, Inc (“Cytovia”), an emerging biopharmaceutical company developing Natural Killer (NK) immunotherapies for cancer, today announces the appointment of Dr. Wei Li as acting Chief Scientific Officer (CSO), effective June 1, 2020. During her biotech career, Dr. Li co-founded two companies and built up extensive expertise in all aspects of drug research and development, including preclinical development and pharmacology, clinical d

TriNet Pharma, Inc., a leading recruiting firm dedicated to placing direct-hire and contract Medical Affairs professionals for life sciences companies in the United States and around the world, today announced the reorganization of its management team in response to the recent passing of Co-Founder and CEO, Bryan Vaughan.

Immunostics Inc. (Boditech USA) and Dr. Scott Benson, an associate professor at the University of Utah Medical School, announce a COVID-19 testing solution and protocol for universities and colleges.

Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS), a company dedicated to developing and delivering medicines that make a clinically meaningful difference to people affected by neurological diseases, today announced that Neil F. McFarlane, the Company’s Chief Executive Officer, is scheduled to present at the William Blair Growth Stock Conference on Wednesday,

MacroGenics, Inc. (NASDAQ: MGNX),today announced research published in the journal Science Translational Medicine that describes a gene expression signature of the tumor microenvironment in patients with acute myeloid leukemia (AML)

China Jo-Jo Drugstores, Inc. announced that it closed its previously announced registered direct offering with certain institutional investors for an aggregate of 5,000,004 shares of the common stock, at a purchase price of $2.00 per share, for aggregate gross proceeds of approximately $10 million to the Company.